The University of Southampton
University of Southampton Institutional Repository

Predicting patient-reported outcomes following treatment for localized prostate cancer: model development and evaluation in an international cohort study

Predicting patient-reported outcomes following treatment for localized prostate cancer: model development and evaluation in an international cohort study
Predicting patient-reported outcomes following treatment for localized prostate cancer: model development and evaluation in an international cohort study
Background and objective: shared decision-making for localized prostate cancer (PCa) requires understanding how baseline factors predict patient-reported outcomes (PROs) after treatment. Most prior predictive models are limited by small, single-region cohorts. We sought to develop and evaluate models predicting 12-month PROs using the large, multi-national Movember True North Global Registry (TNGR).

Methods: we identified 27,499 men with localized PCa across 15 countries (2016–2022). Patients were randomly split into training (n = 18,332) and validation (n = 9,167) cohorts. Multivariable linear regressions incorporated baseline PROs, demographics, country, primary treatment (active surveillance, radical prostatectomy, external-beam radiotherapy ± androgen-deprivation therapy, or brachytherapy), and tumor characteristics (grade, stage, percent positive biopsy cores, PSA). Outcomes were changes from baseline to 12 months across five EPIC-26 domains.

Results: baseline function, treatment modality, and tumor features were associated with 12-month changes across domains. When applied to the validation cohort, model performance explained 15%, 14%, 19%, 32%, and 28% of variance in urinary incontinence, irritative urinary, bowel, sexual, and hormonal function, respectively.

Conclusions: in this first global analysis of functional outcomes after PCa treatment, predictive accuracy was modest, reflecting substantial regional and practice heterogeneity. These findings underscore both the limits of universal prediction models and the value of large-scale international data for benchmarking outcomes. Future TNGR work will focus on region-specific and locally calibrated models to support more personalized counseling and quality-improvement initiatives.
Cohort Studies; Clinical Decision-Making; Prostatic neoplasms / diagnostic imaging; Prostatic neoplasms / epidemiology; Prostatic neoplasms / therapy; Watchful Waiting
1558-7673
Weiner, Adam B.
52d07199-a300-45ac-8c68-283f1667b41b
Richardson, Shannon C.
96901d44-7521-4e46-8c78-1e010736cc2a
Wilhalme, Holly
581893a6-6c70-4a4f-b6e4-b3f019f01326
Bailey, Anissa V.
50527003-a7c4-4685-ab35-491c966b4305
Kwan, Lorna
328cdbee-b762-4240-853a-2b53a1e259cc
Al Hussein Al Awamlh, Bashir
11385258-c9c1-4454-882c-d543a85bff9c
Zhao, Zhiguo
6cdbeaaa-7254-4c20-9c9c-52baabae15a5
Verze, Paolo
ca792022-c5d4-4f80-96f0-17b4d306a269
Ippolito, Juliet
36b68862-bd80-46d0-aca7-1be33f9c23a5
La Rocca, Roberto
fd90bcaa-1cae-4784-bf98-2780a64223cc
Tabea Sibert, Nora
8a8b9a81-1911-4bd0-9d4e-da0c545c38f4
Barocas, Daniel A.
19e3270c-f5ee-46bb-a068-17301e5272b0
Belin, Thomas R.
53f6ac32-1f05-4e75-880b-c436e8e5842f
Elashoff, David
315e313d-3422-4e54-869d-5bd76a78c1f2
Kowalski, Christoph
21bf7ca2-f86c-47b7-ad02-09c72624fd7c
Foster, Claire
00786ac1-bd47-4aeb-a0e2-40e058695b73
Moore, Caroline
782b9499-3fc1-4a9c-af87-6831477ff2c7
Litwin, Mark S.
0fda6105-18b3-42f5-8385-75dbdc18dd4a
Weiner, Adam B.
52d07199-a300-45ac-8c68-283f1667b41b
Richardson, Shannon C.
96901d44-7521-4e46-8c78-1e010736cc2a
Wilhalme, Holly
581893a6-6c70-4a4f-b6e4-b3f019f01326
Bailey, Anissa V.
50527003-a7c4-4685-ab35-491c966b4305
Kwan, Lorna
328cdbee-b762-4240-853a-2b53a1e259cc
Al Hussein Al Awamlh, Bashir
11385258-c9c1-4454-882c-d543a85bff9c
Zhao, Zhiguo
6cdbeaaa-7254-4c20-9c9c-52baabae15a5
Verze, Paolo
ca792022-c5d4-4f80-96f0-17b4d306a269
Ippolito, Juliet
36b68862-bd80-46d0-aca7-1be33f9c23a5
La Rocca, Roberto
fd90bcaa-1cae-4784-bf98-2780a64223cc
Tabea Sibert, Nora
8a8b9a81-1911-4bd0-9d4e-da0c545c38f4
Barocas, Daniel A.
19e3270c-f5ee-46bb-a068-17301e5272b0
Belin, Thomas R.
53f6ac32-1f05-4e75-880b-c436e8e5842f
Elashoff, David
315e313d-3422-4e54-869d-5bd76a78c1f2
Kowalski, Christoph
21bf7ca2-f86c-47b7-ad02-09c72624fd7c
Foster, Claire
00786ac1-bd47-4aeb-a0e2-40e058695b73
Moore, Caroline
782b9499-3fc1-4a9c-af87-6831477ff2c7
Litwin, Mark S.
0fda6105-18b3-42f5-8385-75dbdc18dd4a

Weiner, Adam B., Richardson, Shannon C., Wilhalme, Holly, Bailey, Anissa V., Kwan, Lorna, Al Hussein Al Awamlh, Bashir, Zhao, Zhiguo, Verze, Paolo, Ippolito, Juliet, La Rocca, Roberto, Tabea Sibert, Nora, Barocas, Daniel A., Belin, Thomas R., Elashoff, David, Kowalski, Christoph, Foster, Claire, Moore, Caroline and Litwin, Mark S. (2026) Predicting patient-reported outcomes following treatment for localized prostate cancer: model development and evaluation in an international cohort study. Clinical Genitourinary Cancer, 24 (2), [102504]. (doi:10.1016/j.clgc.2026.102504).

Record type: Article

Abstract

Background and objective: shared decision-making for localized prostate cancer (PCa) requires understanding how baseline factors predict patient-reported outcomes (PROs) after treatment. Most prior predictive models are limited by small, single-region cohorts. We sought to develop and evaluate models predicting 12-month PROs using the large, multi-national Movember True North Global Registry (TNGR).

Methods: we identified 27,499 men with localized PCa across 15 countries (2016–2022). Patients were randomly split into training (n = 18,332) and validation (n = 9,167) cohorts. Multivariable linear regressions incorporated baseline PROs, demographics, country, primary treatment (active surveillance, radical prostatectomy, external-beam radiotherapy ± androgen-deprivation therapy, or brachytherapy), and tumor characteristics (grade, stage, percent positive biopsy cores, PSA). Outcomes were changes from baseline to 12 months across five EPIC-26 domains.

Results: baseline function, treatment modality, and tumor features were associated with 12-month changes across domains. When applied to the validation cohort, model performance explained 15%, 14%, 19%, 32%, and 28% of variance in urinary incontinence, irritative urinary, bowel, sexual, and hormonal function, respectively.

Conclusions: in this first global analysis of functional outcomes after PCa treatment, predictive accuracy was modest, reflecting substantial regional and practice heterogeneity. These findings underscore both the limits of universal prediction models and the value of large-scale international data for benchmarking outcomes. Future TNGR work will focus on region-specific and locally calibrated models to support more personalized counseling and quality-improvement initiatives.

Text
TNGR_predicting_PROs_V9_TRACK - Accepted Manuscript
Restricted to Repository staff only until 16 January 2027.
Request a copy
Text
TNGR predicting PROs V9 TRACK
Restricted to Repository staff only
Request a copy

More information

Accepted/In Press date: 12 January 2026
e-pub ahead of print date: 16 January 2026
Published date: 21 February 2026
Keywords: Cohort Studies; Clinical Decision-Making; Prostatic neoplasms / diagnostic imaging; Prostatic neoplasms / epidemiology; Prostatic neoplasms / therapy; Watchful Waiting

Identifiers

Local EPrints ID: 509441
URI: http://eprints.soton.ac.uk/id/eprint/509441
ISSN: 1558-7673
PURE UUID: 603b73fd-3204-46db-b413-06b250fd7412
ORCID for Claire Foster: ORCID iD orcid.org/0000-0002-4703-8378

Catalogue record

Date deposited: 23 Feb 2026 17:43
Last modified: 24 Feb 2026 02:41

Export record

Altmetrics

Contributors

Author: Adam B. Weiner
Author: Shannon C. Richardson
Author: Holly Wilhalme
Author: Anissa V. Bailey
Author: Lorna Kwan
Author: Bashir Al Hussein Al Awamlh
Author: Zhiguo Zhao
Author: Paolo Verze
Author: Juliet Ippolito
Author: Roberto La Rocca
Author: Nora Tabea Sibert
Author: Daniel A. Barocas
Author: Thomas R. Belin
Author: David Elashoff
Author: Christoph Kowalski
Author: Claire Foster ORCID iD
Author: Caroline Moore
Author: Mark S. Litwin

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×